Pharmaceuticals maker Roche posted a 29% drop in six-month net profit because of costs related to the takeover of Genentech. But Tamiflu sales were strong.
twocents@thestreet.com (The Associated Press), The Street
Thu, 07/23/2009 - 3:56am
Pharmaceuticals maker Roche posted a 29% drop in six-month net profit because of costs related to the takeover of Genentech. But Tamiflu sales were strong.